CD8A and breast cancer: Similarly, targeting of the STAT3 upstream, downregulating the intercellular pSTAT3-Y705 activity and upregulating glycolysis by leptin or PD-1 intervention markedly ameliorated the CD8+ T effector cells function in TME and prevented the development of breast cancer [170].